{"title":"Acute kidney injury is associated with soluble vascular cell adhesion molecule 1 levels and short-term mortality in patients with ischemic stroke","authors":"","doi":"10.1016/j.clineuro.2024.108470","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The mechanisms that modulate the onset of acute kidney inlury (AKI) after ischemic stroke (IS) and valuable biomarkers to predict the occurrence and prognosis of AKI among patients with IS are missing.</p></div><div><h3>Objective</h3><p>To evaluate the frequency of AKI and the prognostic validity of clinical and laboratory biomarkers in predicting AKI and short-term mortality after the IS.</p></div><div><h3>Methods</h3><p>Ninety-five patients with IS were enrolled. Baseline IS severity was assessed using the National Institutes of Health Stroke Scale (NIHSS) and disability was determined after three-month follow-up using the modified Rankin Scale. Patients with IS were also categorized as survivors and non-survivors after the follow-up. Baseline data and laboratory biomarkers were obtained up to 24 h of the admission.</p></div><div><h3>Results</h3><p>Fifteen (15.7 %) patients with IS presented AKI. The proportion of patients with vitamin D deficiency and the mortality were higher among those with AKI than those without AKI (p=0.011 and p-0.009, respectively). Patients with AKI showed higher disability and higher increased soluble vascular cellular adhesion molecule-1 (sVCAM-1) than those without AKI (p=0.029 and p=0.023, respectively). Logistic regression analysis showed that only sVCAM-1 was associated with the occurrence of AKI after IS [odds ratio (OR): 2.715, 95 % confidence intereval (CI): 1.12–6.67, p=0.027]. When both AKI and NIHSS were evaluated as explanatory variables, this panel showed an OR of 5.782 (95 % CI: 1.09–30.43, p<0.001) and correctly classified 83.6 % of cases.</p></div><div><h3>Conclusion</h3><p>In conclusion, sVCAM-1 levels showed a potential useful for prediction of AKI after IS.</p></div>","PeriodicalId":10385,"journal":{"name":"Clinical Neurology and Neurosurgery","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neurology and Neurosurgery","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0303846724003573","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The mechanisms that modulate the onset of acute kidney inlury (AKI) after ischemic stroke (IS) and valuable biomarkers to predict the occurrence and prognosis of AKI among patients with IS are missing.
Objective
To evaluate the frequency of AKI and the prognostic validity of clinical and laboratory biomarkers in predicting AKI and short-term mortality after the IS.
Methods
Ninety-five patients with IS were enrolled. Baseline IS severity was assessed using the National Institutes of Health Stroke Scale (NIHSS) and disability was determined after three-month follow-up using the modified Rankin Scale. Patients with IS were also categorized as survivors and non-survivors after the follow-up. Baseline data and laboratory biomarkers were obtained up to 24 h of the admission.
Results
Fifteen (15.7 %) patients with IS presented AKI. The proportion of patients with vitamin D deficiency and the mortality were higher among those with AKI than those without AKI (p=0.011 and p-0.009, respectively). Patients with AKI showed higher disability and higher increased soluble vascular cellular adhesion molecule-1 (sVCAM-1) than those without AKI (p=0.029 and p=0.023, respectively). Logistic regression analysis showed that only sVCAM-1 was associated with the occurrence of AKI after IS [odds ratio (OR): 2.715, 95 % confidence intereval (CI): 1.12–6.67, p=0.027]. When both AKI and NIHSS were evaluated as explanatory variables, this panel showed an OR of 5.782 (95 % CI: 1.09–30.43, p<0.001) and correctly classified 83.6 % of cases.
Conclusion
In conclusion, sVCAM-1 levels showed a potential useful for prediction of AKI after IS.
背景缺血性卒中(IS)后急性肾损伤(AKI)发病的调节机制以及预测IS患者AKI发生和预后的有价值的生物标志物尚不明确。方法95例IS患者入组。采用美国国立卫生研究院脑卒中量表(NIHSS)评估IS的基线严重程度,采用改良Rankin量表确定随访三个月后的残疾程度。随访结束后,IS 患者还被分为存活者和非存活者。结果15名(15.7%)IS患者出现了AKI。有 AKI 的患者维生素 D 缺乏的比例和死亡率均高于无 AKI 的患者(分别为 p=0.011 和 p-0.009)。与无 AKI 患者相比,AKI 患者的残疾率和可溶性血管细胞粘附分子-1(sVCAM-1)的增加率更高(分别为 p=0.029 和 p=0.023)。逻辑回归分析显示,只有 sVCAM-1 与 IS 后发生 AKI 相关[几率比(OR):2.715,95% 置信区间(CI):1.12-6.67,P=0.027]。当 AKI 和 NIHSS 均作为解释变量进行评估时,该面板显示 OR 为 5.782(95 % CI:1.09-30.43,p<0.001),正确分类了 83.6 % 的病例。
期刊介绍:
Clinical Neurology and Neurosurgery is devoted to publishing papers and reports on the clinical aspects of neurology and neurosurgery. It is an international forum for papers of high scientific standard that are of interest to Neurologists and Neurosurgeons world-wide.